• OPEN AN ACCOUNT
Indian Indices
Sensex
82,031.81 -500.38
( -0.61%)
Global Indices
Nasdaq
50,652.56 -976.61
(-1.89%)
Dow Jones
7,328.13 -109.46
(-1.47%)
Hang Seng
59,089.01 228.58
(0.39%)
Nikkei 225
10,545.68 -144.19
(-1.35%)
Forex
USD-INR
93.96 -0.30
(-0.32%)
EUR-INR
103.45 -0.43
(-0.42%)
GBP-INR
123.99 -0.51
(-0.41%)
JPY-INR
0.59 0.00
(-0.20%)

EQUITY - MARKET SCREENER

UltraTech Cement Ltd
Industry :  Cement - North India
BSE Code
ISIN Demat
Book Value()
532538
INE481G01011
2415.7078673
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ULTRACEMCO
45.65
361306.13
EPS(TTM)
Face Value()
Div & Yield %
268.6
10
1.96
 

srs ltd
Indo US Bio-Tech standalone net profit declines 46.47% in the March 2026 quarter
Jun 01,2026
Net profit of Indo US Bio-Tech declined 46.47% to Rs 1.97 crore in the quarter ended March 2026 as against Rs 3.68 crore during the previous quarter ended March 2025. Sales declined 22.05% to Rs 26.02 crore in the quarter ended March 2026 as against Rs 33.38 crore during the previous quarter ended March 2025.

For the full year,net profit declined 19.36% to Rs 13.12 crore in the year ended March 2026 as against Rs 16.27 crore during the previous year ended March 2025. Sales rose 6.36% to Rs 110.44 crore in the year ended March 2026 as against Rs 103.84 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales26.0233.38 -22 110.44103.84 6
OPM %12.4113.69 -15.4018.24 -
PBDT2.654.43 -40 14.8217.63 -16
PBT2.383.87 -39 13.9216.53 -16
NP1.973.68 -46 13.1216.27 -19